首页> 外文OA文献 >Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy

【2h】

Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy

机译：通过脂质蛋白杂交纳米粒子的分子靶向共递送组蛋白脱乙酰酶抑制剂和紫杉醇，用于协同组合化疗

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Hima Bindu Ruttala; Thiruganesh Ramasamy; Bijay Kumar Poudal; Yongjoo Choi; Ju Yeon Choi; Jeonghwan Kim; Sae Kwang Ku; Han-Gon Choi; Chul Soon Yong; Jong Oh Kim;
展开▼
作者单位

展开▼
年度 2017
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. 组蛋白去乙酰化酶抑制剂协同紫杉醇对人肺癌细胞株抑制作用及机制 [J] . 张东, 刘长庭, 于晓妉, 癌症（英文版） . 2009,第012期
2. Hybrid nanoparticles coated with hyaluronic acid lipoid for targeted co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells [J] . Yang Zhe, Sun Na, Cheng Rui, Journal of Materials Chemistry, B. materials for biology and medicine . 2017,第33期

机译：杂交纳米颗粒涂覆有透明质酸脂醇的靶向共聚的紫杉醇，姜黄素以协同消除乳腺癌干细胞
3. Defining the target specificity of ABT-737 and synergistic antitumor activities in combination with histone deacetylase inhibitors. [J] . Whitecross KF, Alsop AE, Cluse LA, Blood: The Journal of the American Society of Hematology . 2009,第9期

机译：结合组蛋白脱乙酰基酶抑制剂定义ABT-737的靶标特异性和协同抗肿瘤活性。
4. Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin [J] . Rui Mengjie, Xing Yuanrong, Li Ran, Molecular pharmaceutics . 2017,第1期

机译：针对紫杉醇和多柔比星的协同组合化疗的靶向染色纳米粒子
5. Conjugate of Pt (Ⅳ)-Histone Deacetylase Inhibitor as Prodrug for Cancer Chemotherapy [C] . Jun Yang, Weiwei Mao, Xuanrong Sun, World biomaterials congress . 2012

机译：Pt（Ⅳ）-组蛋白脱乙酰基酶抑制剂作为癌症化学疗法的前药。
6. P27 as a molecular target for cancer therapeutics: Discovering small molecule inhibitors of p27 proteolysis and structure-activity relationship and mechanistic studies of largazole, a potent inhibitor of histone deacetylase . [D] . Ungermannova, Dana. 2010

机译：P27作为癌症治疗的分子靶标：发现p27蛋白水解和结构活性关系的小分子抑制剂以及组蛋白脱乙酰基酶的有效抑制剂largazole的机理研究。
7. Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy [O] . Hima Bindu Ruttala, Thiruganesh Ramasamy, Bijay Kumar Poudal, 2017

机译：脂质-蛋白质杂化纳米颗粒分子靶向共递送组蛋白脱乙酰基酶抑制剂和紫杉醇用于协同联合化疗
8. Targeted Biomimetic Nanoparticles for Synergistic Combination Chemotherapy of Paclitaxel and Doxorubicin [O] . -1

机译：针对紫杉醇和多柔比蛋白的协同组合化疗的靶向染色纳米粒子
9. Targeting MTA1/HIF-1alpha Signaling by Pterostilbene in Combination with Histone Deacetylase Inhibitor Attenuates Prostate Cancer Progression (Open Access). [R] . Butt, N. A., Kumar, A., Dhar, S., 2017

机译：通过紫檀芪与组蛋白去乙酰化酶抑制剂组合靶向mTa1 / HIF-1α信号减弱前列腺癌进展（开放存取）。

Molecularly targeted co-delivery of a histone deacetylase inhibitor and paclitaxel by lipid-protein hybrid nanoparticles for synergistic combinational chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅